Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05323149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dexamethasone in Traumatic Brain Injury

StatusRecruiting
PhasePhase 3
Started2022-05-18
View on ClinicalTrials.gov ↗

Amendment history

2026-09-17
Interventions modified
2025-12-27
Study Status, Study Design, Outcome Measures v4
Enrollment target120→60
2025-08-03
Study Status v3
Primary completion date2024-09-10→2027-09-10
Completion date2024-10-15→2027-10-15
2023-12-27
Study Status v2
Primary completion date2023-10-10→2024-09-10
Completion date2023-10-15→2024-10-15
2022-05-18
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-05-01→confirmed 2022-05-18
Study sitesdetails revised at 1 of 1 site
2022-04-11
Original filing
Assiut University
1,604 trials monitored
See 18 trials at risk
In this study, our aim is to investigate the role of Dexamethasone for modulating the inflammation in patients with traumatic brain injury (TBI).
Trial Details
NCT Number NCT05323149
Lead Sponsor Assiut University
Conditions Inflammatory Response
Enrollment 60 participants
Start Date 2022-05-18
Primary Completion 2027-09-10 (estimated)
Study Completion 2027-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-09-16